PAC · DC · C00424838

Novo Nordisk INC. PAC (Novo Nordisk PAC)

A traditional political action committee. It raises limited contributions and can give directly to candidates. Lobbyist/registrant PAC. First filed May 26, 2006. Treasurer: Shoeb Hyder. Connected organization: Novo Nordisk INC. View on FEC.gov (opens in a new tab)

Raised
$419K
Spent
$427K
Cash on hand
$43K
Outside spending
$0

Raised, spent and cash on hand through reports covering Oct. 14, 2026.

Who it spent on

The candidates it spent the most for or against, with how their races turned out. 71 candidates in all.

All 71 candidates
  • Given: the group’s own contributions to the campaign
  • Bundled: donors’ contributions the group collected and forwarded
  • For: outside spending supporting
  • Against: outside spending opposing
    • Given$15K
    • Given$10K
    • Bundled$5K
    • Given$10K
    • Given$10K
    • Given$10K
    • Given$10K
    • Given$8K
    • Given$8K
    • Given$8K
    • Given$8K
    • Given$5K
    • Given$5K
    • Given$5K
    • Given$5K
    • Given$5K
    • Given$5K
    • Given$5K
    • Given$5K
    • Given$5K
    • Given$5K
    • Given$5K
    • Given$4K
    • Given$4K
    • Given$4K
    • Given$4K
    • Given$4K
    • Given$4K
    • Given$4K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$2K
    • Given$2K
    • Given$2K
    • Given$2K
    • Given$2K

Showing the top 50 of 71 candidates.

Bundled contributions (money donors route through a PAC to specific candidates) are broken out only for groups on our issue pages.

Money to parties and other committees

Who funds it

Largest single contributions

Largest single contributions this cycle. Committees and organizations link to their own pages when they file with the FEC; an organization that doesn’t file won’t show its own donors here.

Largest contributions received this cycle
ContributorTypeFromDateAmount
Steven C BenzLegal & Nni General Counsel GVP, Novo Nordisk, INC.PersonCarmel, INSept. 25, 2026$192 (opens in a new tab)
Thomas K ScalesMarket Access And Public Affairs SVP, Novo Nordisk, INC.PersonCary, NCSept. 25, 2026$192 (opens in a new tab)
Christopher A PernieGovernment Affairs Director, Novo Nordisk, INC.PersonBethesda, MDSept. 25, 2026$192 (opens in a new tab)
Colleen P SilkRare Disease GVP, Novo Nordisk, INC.PersonSummit, NJSept. 25, 2026$192 (opens in a new tab)
James G MillarUnited States Operations And Pres Evp, Novo Nordisk, INC.PersonChapel Hill, NCSept. 25, 2026$192 (opens in a new tab)
James G MillarUnited States Operations And Pres Evp, Novo Nordisk, INC.PersonChapel Hill, NCSept. 11, 2026$192 (opens in a new tab)
Colleen P SilkRare Disease GVP, Novo Nordisk, INC.PersonSummit, NJSept. 11, 2026$192 (opens in a new tab)
Christopher A PernieGovernment Affairs Director, Novo Nordisk, INC.PersonBethesda, MDSept. 11, 2026$192 (opens in a new tab)
Thomas K ScalesMarket Access And Public Affairs SVP, Novo Nordisk, INC.PersonCary, NCSept. 11, 2026$192 (opens in a new tab)
Steven C BenzLegal & Nni General Counsel GVP, Novo Nordisk, INC.PersonCarmel, INSept. 11, 2026$192 (opens in a new tab)
James G MillarUnited States Operations And Pres Evp, Novo Nordisk, INC.PersonChapel Hill, NCOct. 9, 2026$192 (opens in a new tab)
Colleen P SilkRare Disease GVP, Novo Nordisk, INC.PersonSummit, NJOct. 9, 2026$192 (opens in a new tab)
Thomas K ScalesMarket Access And Public Affairs SVP, Novo Nordisk, INC.PersonCary, NCOct. 9, 2026$192 (opens in a new tab)
Christopher A PernieGovernment Affairs Director, Novo Nordisk, INC.PersonBethesda, MDOct. 9, 2026$192 (opens in a new tab)
Steven C BenzLegal & Nni General Counsel GVP, Novo Nordisk, INC.PersonCarmel, INOct. 9, 2026$192 (opens in a new tab)
Steven C BenzLegal & Nni General Counsel GVP, Novo Nordisk, INC.PersonCarmel, INAug. 28, 2026$192 (opens in a new tab)
Christopher A PernieGovernment Affairs Director, Novo Nordisk, INC.PersonBethesda, MDAug. 28, 2026$192 (opens in a new tab)
Colleen P SilkRare Disease GVP, Novo Nordisk, INC.PersonSummit, NJAug. 28, 2026$192 (opens in a new tab)
Thomas K ScalesMarket Access And Public Affairs SVP, Novo Nordisk, INC.PersonCary, NCAug. 28, 2026$192 (opens in a new tab)
Colleen P SilkRare Disease GVP, Novo Nordisk, INC.PersonSummit, NJAug. 14, 2026$192 (opens in a new tab)
Christopher A PernieGovernment Affairs Director, Novo Nordisk, INC.PersonBethesda, MDAug. 14, 2026$192 (opens in a new tab)
Steven C BenzLegal & Nni General Counsel GVP, Novo Nordisk, INC.PersonCarmel, INAug. 14, 2026$192 (opens in a new tab)
Negelle Y MorrisCardiometabolic Sales SVP, Novo Nordisk, INC.PersonMartinez, GAJuly 31, 2026$192 (opens in a new tab)
Steven C BenzLegal & Nni General Counsel GVP, Novo Nordisk, INC.PersonCarmel, INJuly 31, 2026$192 (opens in a new tab)
Christopher A PernieGovernment Affairs Director, Novo Nordisk, INC.PersonBethesda, MDJuly 31, 2026$192 (opens in a new tab)

Contributions of $200 or less aren’t listed by name.